Prognosis of patients with wild‐type transthyretin cardiac amyloidosis and non‐sustained ventricular tachycardia
Journal of Cardiovascular Electrophysiology · 2025-01 · 36 (1) · 124-134
DOI: 10.1111/jce.16470 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Electrophysiology, online erschienen am 06.11.2024. Verfasst von Ojasav Sehrawat und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Tachycardia, Ventricular, Amyloid Neuropathies, Familial, Cardiomyopathies, Heart Rate. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Introduction
Little is known regarding the prevalence and prognostic implications of non‐sustained ventricular tachycardia (NSVT) in patients with wild‐type transthyretin cardiac amyloidosis (ATTRwt‐CA). We aimed to investigate the prevalence of NSVT in patients with ATTRwr‐CA, and the association of NSVT with sustained ventricular arrhythmias (VA) and all‐cause mortality.
Methods
In a cohort of ATTRwt‐CA patients from 2011 to 2022 without prior sustained VA, we ascertained the presence and characteristics of NSVT during clinically indicated ambulatory Holter monitoring. Patients were stratified based on the presence of NSVT at baseline. The primary and secondary endpoints of sustained VA and all‐cause mortality, respectively, were assessed during follow‐up.
Results
The cohort included 217 patients with ATTRwt‐CA (95% males, median age 75 years; median NYHA class 2). Baseline Holter monitoring demonstrated NSVT in 116 (53%) patients. During a median follow‐up of 27 months (IQR 16–45) after the index Holter monitor, 11 (5.1%) patients reached the primary endpoint of sustained VA (incidence 1.8 per 100 person‐years, all monomorphic VT), and 46 (21%) patients died. In univariable Cox proportional hazard model, NYHA class 3 or 4 heart failure ( p = .048), the presence of NSVT ( p = .04), the duration of longest NSVT run ( p = .029), and the percentage of ventricular ectopy ( p < .001) were associated with the primary outcome. When adjusting for age and NYHA class 3 or 4 heart failure, the presence of NSVT remained associated with the primary outcome ( p = .03). All‐cause mortality was not significantly different between patients with and without NSVT. A cutoff for ventricular ectopy burden of 0.5%, the median for all patients in this study, was associated with increased risk in sustained VA (log‐rank p = .004) and mortality (log‐rank p = .02).
Conclusion
NSVT is highly prevalent among ATTRwt‐CA patients undergoing clinically indicated Holter monitoring and may confer an increased risk of incident sustained VA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Nursing, Mayo Clinic, Rochester, Minnesota, USA.
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Ojasav Sehrawat, Nicholas Y Tan, Peter A Noseworthy, Konstantinos C Siontis
Zitieren
APA
Sehrawat, O., Swain, W. H., Alcantara, H. P., Tan, N. Y., Abou Ezzeddine, O. F., Grogan, M., Dispenzieri, A., Lin, G., Noseworthy, P. A., & Siontis, K. C. (2025). Prognosis of patients with wild‐type transthyretin cardiac amyloidosis and non‐sustained ventricular tachycardia. Journal of Cardiovascular Electrophysiology, 36(1), 124-134. https://doi.org/10.1111/jce.16470
Vancouver
Sehrawat O, Swain WH, Alcantara HP, Tan NY, Abou Ezzeddine OF, Grogan M, et al. Prognosis of patients with wild‐type transthyretin cardiac amyloidosis and non‐sustained ventricular tachycardia. Journal of Cardiovascular Electrophysiology. 2025;36(1):124-134. doi:10.1111/jce.16470
BibTeX
@article{Sehrawat2025,
author = {Sehrawat, Ojasav and Swain, William H and Alcantara, Hannah P and Tan, Nicholas Y and Abou Ezzeddine, Omar F and Grogan, Martha and Dispenzieri, Angela and Lin, Grace and Noseworthy, Peter A and Siontis, Konstantinos C},
title = {Prognosis of patients with wild‐type transthyretin cardiac amyloidosis and non‐sustained ventricular tachycardia},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2025},
volume = {36},
number = {1},
pages = {124--134},
doi = {10.1111/jce.16470}
}
EUVIMED